Commercialization Consultant Mr. Martin is a transformation and innovation leader with experience driving enterprise initiatives across life science enterprise and large-scale healthcare systems. He has been a serial entrepreneur of biotech startups licensing global assets as well as preparing for the launch and commercialization of specialized pharmaceuticals, medical devices, companion diagnostics, and digital technologies.

With a background spanning service line strategy, operational optimization, and cross-functional execution, Karlo has led initiatives that enhance efficiency with his work building infrastructure and governance models that translate strategic priorities into measurable outcomes across multi-site environments.

Services:

• Venture capital fundraising and non-dilutive fund sourcing
• Market analysis and ecosystem decision intelligence
• Clinical trial data analysis
• Data safety monitoring board development
• Decentralized clinical trial planning and execution
• Grant Writing (STTR/SBIR)
• Product launch and commercialization
• Digital technology developing, triaging, sprint planning, and product development
• Corporate formation/structure
• Basic research, pre-clinical and clinical development
• Service line strategy & growth
• Operational performance & throughput optimization
• Change management, value tracking, and acceleration

Mr. Martin graduated from Florida State University studying Biological Sciences and Molecular Biophysics and from his studies at University Florida in the medical scientist training program became a Clinical Cytogeneticist through the American Society for Clinical Pathology. His research focused on repurposing therapeutics to resensitize patients to failed specialty therapies and developed companion diagnostics to stratify likely responders through precision medicine and pharmacogenomics focusing on solid tumors and diffuse hematological malignancies.

His recent experience has focused on bridging subject matter expertise in healthcare operations and life science product development with a technical acumen developing digital technologies leveraging language models, neuro-symbolic AI, multimodal AI, autonomous agents, robotic process optimization, and Nvidia’s capabilities scaling AI factories.

To work with Commercialization Consultant Mr. Martin, please visit our quote page and request him in the description area.